An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum: In Europe, prostate cancer (PC) is the second most frequent type of cancer in men and the third most lethal. Current clinical practices lead to overdiagnosis and overtreatment, necessitating more effective tools for discriminating between aggressive and non-aggressive disease. The EU-funded ProCAncer-I project proposes to develop advanced artificial intelligence models to address unmet clinical needs: diagnosis, metastases detection and prediction of response to treatment. To achieve this, partners will generate a large interoperable repository of health images, and a scalable high-performance computing platform hosting the largest collection of PC Magnetic Resonance Images used for developing robust PC AI models. To ensure the rapid clinical implementation of the models developed, the project’s partners will robustly monitor performance, accuracy and reproducibility. 

Welcome by Coordinating Team

We are very glad to lead a very ambitious and health-driven project that could end to alleviating and helping thousands of men to tackle prostate cancer in a more personalized way supporting a better quality of life

The Coordinating Team

Manolis Tsiknakis

Prof. Manolis Tsiknakis
(Coordinator)

Dr. Nickolaos Papanickolaou
(Scientific Manager)

Prof. Kostas Marias
(Technical Manager)

Prof. Danielle Regge
(Clinical Manager)

Project information

 

Duration: 01/10/2020-30/09/2024 (48 months)
Total Budget: 9.997.870 €
Topic: DT-TDS-05-2020: AI for Health Imaging
Funded: This project has received funding from the European Union’s Horizon 2020 research and innovation programme
Grant Agreement Nr.: 952159

Highlights

Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη

Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη

Ελπίδα για καλύτερη διάγνωση, θεραπεία και βελτιωμένη ποιότητα ζωής στους ασθενείς που πάσχουν από καρκίνο του προστάτη, δίνει το νέο πανευρωπαϊκό πρόγραμμα ProCAncer-I στο οποίο συμμετέχει και η Ελλάδα καθώς συντονιστής φορέας είναι το Ινστιτούτο Τεχνολογίας και Έρευνας (ΙΤΕ) στην Κρήτη.

Fighting prostate cancer with over 1.5 million MRI images

Fighting prostate cancer with over 1.5 million MRI images

Men die about five years earlier than women across the world. As initiatives to boost awareness of men’s health unfolded in November, an international project is bringing the forefront of AI research to tackle prostate cancer (PC), the second most frequent type of cancer in men and the third most lethal in Europe.

Desde Quirónsalud Marbella indican que todo varón mayor de 45 años debería concertar una visita a su urólogo una vez al año. Y en caso de antecedentes familiares de cáncer de próstata y en vasectomizados esta cita debería programarse antes, a los 40 años http://ow.ly/Rp3v50EgH9F

Save the date! 28 April #aiforindustry, a virtual congress and matchmaking event about #Artificial_Intelligence,
the key to Industry 5.0, co-organized with @secpho. Sign up here: https://bit.ly/3rjeZWj

We’re delighted to announce the official launch of Open Research Europe, the European Commission’s dedicated publishing platform for #Horizon2020 funded research.

Browse Open Research Europe’s first published articles here: https://open-research-europe.ec.europa.eu/

#OpenResearchEurope

Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη
https://www.dimokratianews.gr/ygeia/elpida-ellines-epistimones-karkino-prostati/

Load More...

Stay in touch!